Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.6853+0.0122 (+1.81%)
At close: 04:00PM EDT
0.7100 +0.02 (+3.60%)
After hours: 05:30PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 3-90.16%
S&P500 52-week change 3-10.33%
52-week high 37.7000
52-week low 30.6200
50-day moving average 30.8248
200-day moving average 32.9109

Share statistics

Avg vol (3-month) 3169.1k
Avg vol (10-day) 3114.2k
Shares outstanding 536.19M
Implied shares outstanding 6N/A
Float 823.18M
% held by insiders 110.49%
% held by institutions 119.20%
Shares short (14 Mar 2023) 4175.11k
Short ratio (14 Mar 2023) 40.55
Short % of float (14 Mar 2023) 40.50%
Short % of shares outstanding (14 Mar 2023) 40.48%
Shares short (prior month 14 Feb 2023) 4492.01k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-17,696.77%

Management effectiveness

Return on assets (ttm)-62.05%
Return on equity (ttm)-104.75%

Income statement

Revenue (ttm)195.02k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)75.20%
Gross profit (ttm)-21.21M
EBITDA -34.17M
Net income avi to common (ttm)-34.45M
Diluted EPS (ttm)-1.3300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.15M
Total cash per share (mrq)0.51
Total debt (mrq)208.15k
Total debt/equity (mrq)1.15
Current ratio (mrq)8.18
Book value per share (mrq)0.71

Cash flow statement

Operating cash flow (ttm)-30.52M
Levered free cash flow (ttm)-19.13M